Emergency Clinician

With the suPARnostic® prognosis for risk of disease progression there is now a reliable tool to aid in prioritizing patients in the Emergency Department. Numerous publications have confirmed suPARnostic® as a novel marker for risk prediction and emergency departments are starting to implement this novel concept for risk stratification.

Identifying a patient's suPARnostic® level upon presentation to hospitals or clinics will enable clinicians to assess which patients require immediate attention and further testing in order to ensure timely treatment.

MD, Assistant Professor, Harvard Medical School, ER, Beth Israel Deaconess Medical Center, Boston:
"If test results such as lab data and imaging data are immediately available..., hospital staff will win valuable time, which can improve patient flow and ultimately save lives"

MD, Chief Physician Inger Søndergaard, Herlev Hospital, Copenhagen:
"The key challenge for the ER is to indentify the ill patients faster, make diagnosis faster, find the right specialist faster and initiate the right treatment faster"

The suPAR level is associated with presence, severity and progression of disease, and in unselected patients, suPAR is one of the strongest prognostic biomarkers available to date. 

Here you can find a short summary of the research done on suPAR within 12 groups of disease areas, and see how the suPAR level is affected within each kind of disease. 

Please find the suPAR Monograph here:

 suPAR Monograph pdfsuPAR Monograph 

The benefits of the suPARnostic® test in the Emergency Department are :

  • Gives a faster result than any of the risk scores currently in use – because it is a quick biomarker test
  • Adds information - to allow the clinician to prioritize patients risk of disease progression
  • Simplifies procedures - because it is easy and simple to use

suPAR can improve patient triage in the Emergency Department

suPAR is in routine use in the Emergency Department at Copenhagen University Hospital Hvidovre, Denmark.
"The suPAR level can give an indication of whether the patient suffers from a severe disease and what the prognosis of the patient is..... is the patient severely ill?"

See the interview with the Head of the Emergency Department at Hvidovre Hospital and hear why they use the biomarker suPAR in routine use at the hospital.

For more information please also read:

Using suPAR as a Clinical Aid

suPARnostic® Risk Scale and test options

suPAR biomarker and biology

suPAR is proposed as a robust and reliable prognostic tool for patient risk of disease progression.
suPAR was shown to be a potential assessment tool in the Emgergency Department [Uusitalo Seppälä et al., 2012, Koch A & Tacke F, 2012; Haupt T. et al., 2012] in addition to earlier studies demonstrating its value within critical care [Kofoed et al., 2006]. 
This is of clear importance as economic as well as patient survival considerations are calling for better tools to evaluate the state of patients upon hospital admission.


1. 40 year old male with sore throat. Temperature: 38.5 °C. CRP 144, WBC 19.9, neutrophils 16.6
- Guess the suPAR level upon Emergency Room arrival

2. 65 year old female fainted at home. Vital parameters normal. Biochemistry normal
- Guess the suPAR level upon Emergency Room arrival

See answers here.